23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Huntington’s Disease and Diabetes: Chronological Sequence of its Association

      review-article
      a , b , c , d , *
      Journal of Huntington's Disease
      IOS Press
      Chorea, diabetes, glucose metabolism, Huntington’s disease, neurosyndromes

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although Huntington’s disease (HD) is primarily considered a rare neurodegenerative disorder, it has been linked to glucose metabolism alterations and diabetes, as has been described in other neuro syndromes such as Friedreich’s ataxia or Alzheimer’s disease. This review surveys the existing literature on HD and its potential relationship with diabetes, glucose metabolism-related indexes and pancreas morphology, in humans and in animal’s models. The information is reported in chronological sequence. That is, studies performed before and after the identification of the genetic defect underlying HD (CAG: encoding glutamine ≥36 repeats located in exon 1 of the HTT gene) and with the development and evolution of HD animal models. The aim of the review is to evaluate whether impaired glucose metabolism contributes to the development of HD, and whether optimized glycemic control may ameliorate the symptoms of HD.

          Related collections

          Most cited references64

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management

          Type 2 diabetes mellitus (T2DM) is a global pandemic, as evident from the global cartographic picture of diabetes by the International Diabetes Federation (http://www.diabetesatlas.org/). Diabetes mellitus is a chronic, progressive, incompletely understood metabolic condition chiefly characterized by hyperglycemia. Impaired insulin secretion, resistance to tissue actions of insulin, or a combination of both are thought to be the commonest reasons contributing to the pathophysiology of T2DM, a spectrum of disease originally arising from tissue insulin resistance and gradually progressing to a state characterized by complete loss of secretory activity of the beta cells of the pancreas. T2DM is a major contributor to the very large rise in the rate of non-communicable diseases affecting developed as well as developing nations. In this mini review, we endeavor to outline the current management principles, including the spectrum of medications that are currently used for pharmacologic management, for lowering the elevated blood glucose in T2DM.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Risk of dementia among persons with diabetes mellitus: a population-based cohort study.

            It is unclear whether persons with diabetes are at increased risk for dementia, including Alzheimer's disease. Existing studies are limited by small sample size, selection bias, and case-control designs. This population-based historical cohort study provides estimates of the risk of dementia and Alzheimer's disease associated with adult onset diabetes mellitus (AODM). The sample included all persons with AODM residing in Rochester, Minnesota, on January 1, 1970, plus all persons diagnosed in Rochester or who moved to Rochester with the diagnosis between January 1, 1970, and December 31, 1984. Individuals were followed through review of their complete medical records from AODM diagnosis until dementia onset, emigration, death, or January 1, 1985. Standardized morbidity ratios for dementia and Alzheimer's disease were calculated, using an expected incidence based on age- and sex-specific rates for the Rochester population. Poisson regression was used to estimate risks for persons with AODM relative to those without. Of the 1,455 cases of AODM followed for 9,981 person-years, 101 developed dementia, including 77 who met criteria for Alzheimer's disease. Persons with AODM exhibited significantly increased risk of all dementia (Poisson regression relative risk (RR) = 1.66, 95% confidence interval (CI) 1.34-2.05). Risk of Alzheimer's disease was also elevated (for men, R = 2.27, 95% CI 1.55-3.31; for women, RR = 1.37, 95% CI 0.94-2.01). These findings emphasize the importance of AODM prevention and prompt additional investigation of the relation between AODM and dementia.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Delaying the onset of Huntington's in mice.

                Bookmark

                Author and article information

                Journal
                J Huntingtons Dis
                J Huntingtons Dis
                JHD
                Journal of Huntington's Disease
                IOS Press (Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands )
                1879-6397
                1879-6400
                29 September 2017
                2017
                : 6
                : 3
                : 179-188
                Affiliations
                [a ]Department of Neurology, Movement Disorders Unit, Fundación Jiménez Díaz, Madrid, Spain
                [b ]Division of Endocrinology, Fundación Jiménez Díaz, Madrid, Spain
                [c ]Renal, Vascular and Diabetes Research Laboratory, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Autónoma University , Madrid, Spain
                [d ] Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) network , Madrid, Spain
                Author notes
                [* ]Correspondence to: Nieves González, PhD, Renal, Vascular and Diabetes Research Laboratory, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Autónoma University, Madrid, Av. Reyes Católicos 2, Madrid 28040, Spain. Tel.: +34 915504899; E-mail: ngonzalezg@ 123456quironsalud.es .
                Article
                JHD170253
                10.3233/JHD-170253
                5676851
                28968242
                fe5fe526-fd75-4c4b-993d-8ad525e22a85
                © 2017 – IOS Press and the authors. All rights reserved

                This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Categories
                Review

                chorea,diabetes,glucose metabolism,huntington’s disease,neurosyndromes

                Comments

                Comment on this article